Innovating Complex Therapeutics at Europe’s Premier Platform for TIDES Thought Leadership

Abzena is the leading end-to-end bioconjugate, antibody-drug conjugate (ADC), and complex biologics CDMO + CRO. From early discovery through commercial launch, we support customers with fully integrated programs or individual services designed to de-risk and streamline the development and manufacture of new treatments for patients in need. With the ability to tailor our strategy and customer experience to each project, Abzena develops and implements innovative solutions, like our next generation site-specific conjugation technology, ThioBridge™, that’s been proven to improve the safety, efficacy, and potency of ADCs and bioconjugates. The company has research, development, and stateof-art cGMP facilities with high potency handling capabilities across locations in San Diego, CA, Bristol, PA, and Cambridge, UK- thus enabling us to move medicines forward faster and with greater success.

Proteintech Group: For Scientists, By Scientists

Proteintech Group was founded in 2001 by a group of scientists, who were actively engaged in NIH funded research at the time. One of the original founders and current CEO Dr. Jason Li was an Associate Professor of Immunology at the University of Illinois at Chicago during the company's foundation years. He says of the reasons behind Proteintech's establishment:

"AT THE HEART OF OUR ASPIRATION WAS A COMPANY FOR SCIENTISTS BY SCIENTISTS; AN ANTIBODY PROVIDER THAT WOULD OFFER RESEARCHERS THE ADVANTAGE — NOT INVESTORS."

As a company founded by scientists, Proteintech Group recognises the tireless efforts and sacrifices made by researchers to advance scientific discovery.

Proteintech aims to match its’ customers’ dedication to research by providing high quality, reliable reagents that contribute to reproducible results.

‍

Your biotech company since 1985

Eurogentec is a biotechnology company providing life science products and personalized services to academic, medical and industrial scientists world-wide.

We are also a trusted CDMO internationally recognized for the development and production of biopharmaceutical critical raw materials and therapeutic molecules.

Based in Belgium, Eurogentec is a member of Kaneka Corporation.

‍